Ganga Pharmaceuticals Shareholding Pattern

As of Mar 2026, Ganga Pharmaceuticals (GANGAPHARM) promoter holding 50.91%, FII 0.00%, DII 0.00%, public 35.32%, total shareholders 365. Explore Ganga Pharmaceuticals intrinsic worth to estimate fundamental worth using multiple valuation models.

Promoter Holding 50.91%

FII Holding 0.00%

DII Holding 0.00%

Public Holding 35.32%

Total Shareholders 365

As of Mar 2026

GANGAPHARM Recent Shareholding Changes — Promoter, FII & DII

Ganga Pharmaceuticals promoter, FII and DII holding change from Sept 2025 to Mar 2026. For live price, key ratios and the full company profile, see GANGAPHARM screener.

Promoter Holding Change

Sept 2025 to Mar 2026

No Change

FII Holding Change

Sept 2025 to Mar 2026

No Change

DII Holding Change

Sept 2025 to Mar 2026

No Change

Public Holding Change

Sept 2025 to Mar 2026

No Change

Ganga Pharmaceuticals Quarterly Shareholding Trend — Promoter, FII, DII & Public

GANGAPHARM promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Browse GANGAPHARM cash flow statement for revenue, profit, balance sheet and cash flow data.

Promoter

FII

DII

Public

Government

GANGAPHARM Shareholding Pattern Data — Quarterly History

Ganga Pharmaceuticals quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period	Promoter (%)	FII (%)	DII (%)	Govt (%)	Public (%)	Other (%)	Total (%)	Shareholders
Mar 2026	50.91%	0.00%	0.00%	0.00%	35.32%	13.77%	100.00%	365
Sept 2025	50.91%	0.00%	0.00%	0.00%	35.32%	13.77%	100.00%	366
Jul 2025	50.91%	0.00%	0.00%	0.00%	35.46%	13.63%	100.00%	367
Jun 2025	50.91%	0.00%	0.00%	0.00%	35.46%	13.63%	100.00%	367
Mar 2025	56.02%	0.00%	0.00%	0.00%	35.07%	8.91%	100.00%	368
Sept 2024	56.02%	0.00%	0.00%	0.00%	35.23%	8.75%	100.00%	365
Mar 2024	56.02%	0.00%	0.00%	0.00%	35.40%	8.58%	100.00%	363
Dec 2023	56.02%	0.00%	0.00%	0.00%	35.23%	8.75%	100.00%	362
Sept 2023	66.71%	0.00%	0.00%	0.00%	31.91%	1.38%	100.00%	359
Mar 2023	66.71%	0.00%	0.00%	0.00%	31.91%	1.38%	100.00%	356
Sept 2022	66.71%	0.00%	0.00%	0.00%	31.91%	1.38%	100.00%	355
Jun 2022	66.71%	0.00%	0.00%	0.00%	32.30%	0.98%	99.99%	356
Mar 2022	66.71%	0.00%	0.00%	0.00%	32.50%	0.79%	100.00%	356
Dec 2021	66.71%	0.00%	0.00%	0.00%	32.30%	0.98%	99.99%	354
Sept 2021	66.71%	0.00%	0.00%	0.00%	32.30%	0.98%	99.99%	354
Jun 2021	66.71%	0.00%	0.00%	0.00%	32.11%	1.18%	100.00%	354
Mar 2021	66.71%	0.00%	0.00%	0.00%	32.11%	1.18%	100.00%	354

Quarter	Promoter (%)	FII (%)	DII (%)	Govt (%)	Public (%)	Other (%)	Total (%)	Shareholders
Mar 2026	50.91%	0.00%	0.00%	0.00%	35.32%	13.77%	100.00%	365
Sept 2025	50.91%	0.00%	0.00%	0.00%	35.32%	13.77%	100.00%	366
Jul 2025	50.91%	0.00%	0.00%	0.00%	35.46%	13.63%	100.00%	367
Jun 2025	50.91%	0.00%	0.00%	0.00%	35.46%	13.63%	100.00%	367
Mar 2025	56.02%	0.00%	0.00%	0.00%	35.07%	8.91%	100.00%	368
Sept 2024	56.02%	0.00%	0.00%	0.00%	35.23%	8.75%	100.00%	365
Mar 2024	56.02%	0.00%	0.00%	0.00%	35.40%	8.58%	100.00%	363
Dec 2023	56.02%	0.00%	0.00%	0.00%	35.23%	8.75%	100.00%	362
Sept 2023	66.71%	0.00%	0.00%	0.00%	31.91%	1.38%	100.00%	359
Mar 2023	66.71%	0.00%	0.00%	0.00%	31.91%	1.38%	100.00%	356
Sept 2022	66.71%	0.00%	0.00%	0.00%	31.91%	1.38%	100.00%	355
Jun 2022	66.71%	0.00%	0.00%	0.00%	32.30%	0.98%	99.99%	356

Year	Promoter (%)	FII (%)	DII (%)	Govt (%)	Public (%)	Other (%)	Total (%)	Shareholders
Mar 2026	50.91%	0.00%	0.00%	0.00%	35.32%	13.77%	100.00%	365
Mar 2025	56.02%	0.00%	0.00%	0.00%	35.07%	8.91%	100.00%	368
Mar 2024	56.02%	0.00%	0.00%	0.00%	35.40%	8.58%	100.00%	363
Dec 2023	56.02%	0.00%	0.00%	0.00%	35.23%	8.75%	100.00%	362
Mar 2022	66.71%	0.00%	0.00%	0.00%	32.50%	0.79%	100.00%	356
Dec 2021	66.71%	0.00%	0.00%	0.00%	32.30%	0.98%	99.99%	354